MASTL regulates EGFR signaling to impact pancreatic cancer progression-Reference-Cited by-同舟云学术

MASTL regulates EGFR signaling to impact pancreatic cancer progression

Published:2021-07-30 Issue:38 Volume:40 Page:5691-5704
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Fatima Iram,Barman Susmita,Uppada JayaPrakash,Chauhan Shailender^ORCID,Rauth Sanchita,Rachagani Satyanarayana,Ponnusamy Moorthy Palanimuthu^ORCID,Smith Lynette,Talmon Geoffrey,Singh Amar B.,Batra Surinder K.^ORCID,Dhawan Punita^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-021-01951-x.pdf

Reference61 articles.

1. Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008–20.

2. Kleespies A, Jauch KW, Bruns CJ. Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer? Drug Resist Updat. 2006;9:1–18.

3. Ruess DA, Gorgulu K, Wormann SM, Algul H. Pharmacotherapeutic management of pancreatic ductal adenocarcinoma: current and emerging concepts. Drugs Aging. 2017;34:331–57.

4. Fatima I, Singh AB, Dhawan P. MASTL: a novel therapeutic target for cancer malignancy. Cancer Med. 2020;9:6322–9.

5. Marzec K, Burgess A. The oncogenic functions of MASTL kinase. Front Cell Dev Biol. 2018;6:162.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-22 regulates MASTL expression in intestinal epithelial cells;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01

2. Molecular Classification and Pathogenesis of Pancreatic Adenocarcinoma and Targeted Therapies: A Review;Frontiers in Bioscience-Landmark;2024-03-13

3. Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds;Journal of Asian Natural Products Research;2024-02-19

4. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20;British Journal of Cancer;2024-01-26

5. LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway;Medical Oncology;2023-07-31